Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Biocompatibility implantation therapy

Having confirmed pCPPrSA pol3rmers are (i) biocompatible and non-toxic with BCNU-loading and possible radiation therapy, (ii) capable of broad BCNU distribution from the implantation site, and (iii) more effective delivery systems than systemic BCNU in animal survival studies, research development progressed to a multicenter phase I-II chnical... [Pg.337]

Regulatory guidelines instruct that implant leachates should not produce adverse local, systemic, tumorigenic, reproductive, or developmental effects to be approved. Evaluations of biocompatibility, which are described in these standards, are all part of the overall safety and efficacy assessment of medical devices and advanced therapy medical products, for example, scaffolds for tissue engineering, tissue adhesives, hip replacements, and surgical meshes for tissue support. [Pg.567]

The attachment of proteins and other biomolecules to PEG-grafted surfaces is also of interest for a number of applications. In solid-phase immunoassay and extracorporeal therapy, antibodies or other bioactive molecules are immobilized to a support that interacts with cells, blood, or plasma. Biocompatibility of implants and artificial organs can be improved by the attachment of growth factors to the surface via PEG spacers. These applications are all based on the regulating function of PEG in the interaction between a biomolecule, usually a protein, and another biomolecule or cell. More specifically, immobilization of the biologically active molecules to the free end of grafted PEG chains offers a way to minimize the interactions (deformation and nonspecific adsorption) of attached biomolecules with underlying surface, thus maximize the functions of immobilized biomolecules. [Pg.67]

Hydrogels are macromolecular materials with a water content of 30 to 90%. They provide fairly good biocompatibility, being adequate materials for catheter sutures, blood detoxificants, artificial sensors, ophthalmologic protection (contact lenses, artificial cornea), conjunctive tissue substitution, bum therapy, dental implants, aesthetic surgery, and immobilization of bioactive agents. [Pg.154]

Keywords Polymers Cardiology Implant Drug-eluting stent Drug-coated balloon Transcatheteraortic valve therapy Local drug delivery Biofunctionalization Biocompatibility Hemocompatibility... [Pg.434]

Diagnostic and therapeutical treatments implicate the contact between tissue, blood and the implanted material. In the cardiovascular field, a variety of biomaterial is implanted in heart and vessels, such as catheters, stents, heart valves and sondes for pacemakers and defibrillators. Using polymers for new technologies has been a revolutionary advance in the therapy of cardiovascular disease [47]. Nevertheless, there is increasing evidence that the polymer coating could be responsible for adverse effects (e.g. in-stent-restenosis, stent thrombosis, chronicle foreign body reactions). Therefore, a feasible biocompatible material should provide a complete re-endothelialisation of the surface, less thrombogenicity as well as anti-inflammatory properties in order to improve clinical outcomes. [Pg.455]

Each application mentioned above demands materials with specific physical, chemical, biological, biomechanical and degradation properties to provide efficient therapy. Above all, the vital prerequisite for a polymer to be used in the biomedical field is biocompatibility, which is the ability of a material to perform with an appropriate host response in a specific application. For instance, there were several important properties listed for materials used in implantation. [Pg.367]

Other related areas include the creation of new biocompatible dehvery systems for cellular therapy and agricultural fertilizers [22, 23]. It has been suggested that nanophase calcium phosphates can mimic the dimensions of constituent components of natural tissues, and consequently nanocalcium phosphates can be utihzed for tissue-engineered implants with improved biocompatibility [24]. In this respect, it is the development of calcium phosphate biomedical materials that stands to benefit most from such nanotechnology. [Pg.450]


See other pages where Biocompatibility implantation therapy is mentioned: [Pg.141]    [Pg.298]    [Pg.130]    [Pg.411]    [Pg.100]    [Pg.1264]    [Pg.3123]    [Pg.52]    [Pg.56]    [Pg.208]    [Pg.143]    [Pg.564]    [Pg.141]    [Pg.361]    [Pg.52]    [Pg.334]    [Pg.376]    [Pg.65]    [Pg.354]    [Pg.284]    [Pg.148]    [Pg.517]    [Pg.4357]    [Pg.107]    [Pg.29]    [Pg.495]    [Pg.287]    [Pg.148]    [Pg.375]    [Pg.81]    [Pg.529]    [Pg.213]    [Pg.152]    [Pg.470]    [Pg.79]    [Pg.163]    [Pg.64]    [Pg.67]    [Pg.287]    [Pg.321]    [Pg.334]    [Pg.127]   
See also in sourсe #XX -- [ Pg.87 ]




SEARCH



Biocompatibility

Biocompatibility implants

Implantation therapy

© 2024 chempedia.info